Pancreatic Stent for Distal Pancreatectomy

Ruijin Hospital120 enrolled

Overview

The purpose of this study is to compare outcomes of patients undergoing distal pancreatectomy with or without pancreatic stent

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

120

Conditions

Distal Pancreatectomy

Interventions

Pancreatic stent: PSOF COOK®DEVICE

After removing the distal pancreas, PSOF COOK will be place in the main pancreatic duct

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Patients undergoing distal pancreatectomy 2. Signed the informed consents Exclusion Criteria: 1. Recurrence patients 2. pre-operative anti-cancer treatment 3. patients with contraindication(hepatic/ respiratory/ renal dysfunction, etc ) 4. AJCC stage IV 5. pre operative oddi'ssphincter incision 6. operation non radical 7. pancreatic stent not at place

Locations (1)

Shanghai Ruijin Hospital

Shanghai, Shanghai Municipality, China

Outcomes

Primary Outcomes

all-cause mortality / complications

mortality, pancreatic fistula, Biliary fistula，bleeding， etc

Time frame: Hospitalization 30days（duration of hospital stay)

Secondary Outcomes

all-cause mortality / complications

mortality, pancreatic fistula, Biliary fistula，bleeding， etc

Time frame: 30 days after operation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.